No Data
No Data
J&J Says Rybrevant Combo Bests AstraZeneca's Tagrisso in Type of Lung Cancer
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 10 Years
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 6.43% on an annualized basis producing an average annual return of 16.92%. Currently, Thermo Fisher Scientific
Immunocore Touts Updated Phase 1 Results for Melanoma Asset Brenetafusp
UnitedHealth on Track to Break Six Straight Days of Losses
Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years
Amgen (NASDAQ:AMGN) has outperformed the market over the past 20 years by 1.01% on an annualized basis producing an average annual return of 8.86%. Currently, Amgen has a market capitalization of $161
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
FiReBiTriXiE : Think you’re on to something here really if history repeats itself the health sector should be rising with the statistics you shared